87 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
workforce representation and increased community engagement by the company's employees;
◦Advancing climate action goals and increasing the company's
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
renewable source by 2026 through VPPA*
Committed to Sound Corporate Governance 6 Board Accountability and Shareholder Rights Regular shareholder engagement … shareholder engagement “Double-trigger” change-in-control agreements No guaranteed incentive with our Named Executive Officers Prohibition on speculative
SC TO-C
EX-99.2
5q3o sc9ec
26 Dec 23
Information about tender offer
4:22pm
DEFA14A
h4al2zohkgv86h10
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.3
kou2 0yoxqmqkngvz4z
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
ub6tdbkj8i56mqyjjyr
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.3
hnbvkr
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
3okei02t cmz4f
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-3
nnv66
4 May 21
Departure of Directors or Certain Officers
4:16pm
DEFA14A
nvmznwo3s
19 Apr 21
Additional proxy soliciting materials
7:41am